• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of anti-fibrotic effects of lipid-responsible transcription factors and a search for new therapeutic agents -with special attention to hypoxic insults-

Research Project

Project/Area Number 24591193
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Kidney internal medicine
Research InstitutionUniversity of Fukui

Principal Investigator

KIMURA Hideki  福井大学, 医学部附属病院, 准教授 (20283187)

Co-Investigator(Kenkyū-buntansha) IWANO Masayuki  福井大学, 医学部, 教授 (20275324)
KASUNO Kenji  福井大学, 医学部, 准教授 (60455243)
SUGAYA Takeshi  聖マリアンナ医科大学, 医学部, 客員教授 (40381561)
Project Period (FY) 2012-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywordsペルオキシゾーム増殖因子活性化受容体 / 脂肪酸結合蛋白 / 近位尿細管上皮細胞 / メサンギウム細胞 / サイトカイン / アンジオテンシンⅡ受容体拮抗薬 / ドキソルビシン / 進行性腎障害 / 尿細管上皮細胞 / L-FABP / PPAR / 抗線維化作用 / 抗炎症作用
Outline of Final Research Achievements

Proximal tubular epithelial cells (PT)and mesangial cells (MC) are closely associated with renal fibrosis. Mouse proximal tubular epithelial cells (mProx) overexpressing human liver-type fatty acid-binding protein (L-FABP) were shown to have greater tolerance to inflammatory and hypoxic insults than mProx itself. In human cultured PT and MC, telmisartan (ARB) executed PPAR-delta functions and reduced inflammatory and pro-fibrotic effects induced by some cytokines.
Cardiac fibrosis of PPAR-a KO mice was more evident than that of control mice (S129), which was enhanced by hypoxic environments, whereas renal fibrosis was scarcely observed and similar in the two mice groups. In doxorubicin-induced glomerulopathy, PPAR-a KO mice had more proteinuria and more frequent glomerulosclerosis than S129 mice.
These suggest the cell- and tissue-protective effects of lipid responsible transcription factors and its associated proteins such as PPARs and FABPs.

Report

(4 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • 2012 Research-status Report
  • Research Products

    (22 results)

All 2015 2014 2013 Other

All Journal Article (5 results) (of which Peer Reviewed: 4 results,  Open Access: 3 results,  Acknowledgement Compliant: 3 results) Presentation (17 results)

  • [Journal Article] A heterozygous female with Fabry disease due to a novel alpha-galactosidase A mutation exhibits a unique synaptopodin distribution in vacuolated podocytes2015

    • Author(s)
      N.Takahashi, S.Yokoi, K.Kasuno, A.Kogami, T.Tsukimura, T.Togawa, S.Saito, K.Ohno, M.Hara, H.Kurosawa, Y.Hirayama, T.Kurose, Y.Yokoyama, D.Mikami, H.Kimura, H.Naiki, H.Sakuraba, M.Iwano
    • Journal Title

      Clin Nephrol

      Volume: 未定

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Telmisartan, a possible PPAR-δ agonist, reduces TNF-α-stimulated VEGF-C production by inhibiting the p38MAPK/HSP27 pathway in human proximal renal tubular cells.2014

    • Author(s)
      Kimura H, Iwano M, et al
    • Journal Title

      Biochem Biophys Res Commun.

      Volume: 454 Issue: 2 Pages: 320-327

    • DOI

      10.1016/j.bbrc.2014.10.077

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Renal redox dysregulation in AKI: application for oxidative stress marker of AKI.2014

    • Author(s)
      Kasuno K, Iwano M, et al.
    • Journal Title

      Am J Physiol Renal Physiol.

      Volume: 307 Issue: 12 Pages: 1342-1351

    • DOI

      10.1152/ajprenal.00381.2013

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Telmisartan activates endogenous peroxisome proliferator-activated receptor-δ and may have anti-fibrotic effects in human mesangial cells.2014

    • Author(s)
      Mikami D, Iwano M, et al.
    • Journal Title

      Hypertens Res.

      Volume: 37 Issue: 5 Pages: 422-431

    • DOI

      10.1038/hr.2013.157

    • Related Report
      2013 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] 進行性腎障害におけるペルオキシゾーム増殖薬活性化受容体(PPAR)の免疫調節作用の解析2013

    • Author(s)
      木村秀樹
    • Journal Title

      福井大学 重点研究成果集 明日への挑戦

      Volume: 8 Pages: 1-2

    • Related Report
      2013 Research-status Report 2012 Research-status Report
  • [Presentation] 新規バイオマーカーとしての尿中PAI-1の臨床的意義2015

    • Author(s)
      鳥居 国雄、木村 秀樹、上山 和子、三上 大輔、高橋 直生、糟野 健司、岩野 正之
    • Organizer
      第58回日本腎臓学会学術総会
    • Place of Presentation
      名古屋市 国際会議場
    • Year and Date
      2015-06-05 – 2015-06-07
    • Related Report
      2014 Annual Research Report
  • [Presentation] PPAR-δ活性化能を有するアンジテンシンII受容体阻害薬のミトコンドリア機能調節作用の解析2015

    • Author(s)
      三上 大輔、木村 秀樹、上山 和子、横井 靖二、西川 雄大1、森田 紗由、今田 麻美子、高橋 直生、糟野 健司、岩野 正之
    • Organizer
      第58回日本腎臓学会学術総会
    • Place of Presentation
      名古屋市 国際会議場
    • Year and Date
      2015-06-05 – 2015-06-07
    • Related Report
      2014 Annual Research Report
  • [Presentation] ピタバスタチンによるコレステリルエステル転送蛋白発現抑制の分子機序の解析(臨床と基礎研究からの推測)2014

    • Author(s)
      嶋田 章弘, 上山 和子, 飛田 征男, 久田 恭子, 吉田 治義, 平野 勉, 岩野 正之, 木村 秀樹
    • Organizer
      第61回日本臨床検査医学会学術集会
    • Place of Presentation
      福岡市 福岡国際会議場
    • Year and Date
      2014-11-22 – 2014-11-25
    • Related Report
      2014 Annual Research Report
  • [Presentation] A heterozygous female with Fabry disease due to a novel α-galactosidase A mutation (Pro210Ser)exhibits a unique synaptopodin distribution in vacuolated podocytes2014

    • Author(s)
      M.Imada, N.Takahashi, S.Yokoi, K.Kasuno, Y.Yokoyama, D.Mikami, H.Kimura, M.Hara, M.Iwano
    • Organizer
      American Society of Nephrology (Kidney Week 2014).
    • Place of Presentation
      Philadelphia, United States
    • Year and Date
      2014-11-11 – 2014-11-16
    • Related Report
      2014 Annual Research Report
  • [Presentation] 蛋白尿の種類と検査法ー新規バイオマーカーを含めてー2014

    • Author(s)
      木村 秀樹
    • Organizer
      第57回日本腎臓学会学術総会
    • Place of Presentation
      横浜市 パシフィコ横浜 会議センター
    • Year and Date
      2014-07-04 – 2014-07-06
    • Related Report
      2014 Annual Research Report
  • [Presentation] Beads法を用いた単離マウス糸球体における低酸素高糖刺激による糸球体mRNAの解析2014

    • Author(s)
      高橋 直生, 糟野 健司, 上山 和子, 横井 靖二, 黒澤 寛之, 横山 由就, 三上 大輔, 木村 秀樹, 吉田 治義, 原 正則, 岩野 正之
    • Organizer
      第57回日本腎臓学会学術総会
    • Place of Presentation
      横浜市 パシフィコ横浜 会議センター
    • Year and Date
      2014-07-04 – 2014-07-06
    • Related Report
      2014 Annual Research Report
  • [Presentation] 新規TLR4阻害因子・分泌型FSP1を介したポドサイトーメサンギウム細胞連関2014

    • Author(s)
      横井 靖二, 糟野 健司, 高橋 直生, 三上 大輔, 横山 由就, 木村 秀樹, 岩野 正之
    • Organizer
      第57回日本腎臓学会学術総会
    • Place of Presentation
      横浜市 パシフィコ横浜 会議センター
    • Year and Date
      2014-07-04 – 2014-07-06
    • Related Report
      2014 Annual Research Report
  • [Presentation] 腎障害と蛋白尿 -新規尿バイオマーカーを含めてー2014

    • Author(s)
      木村 秀樹
    • Organizer
      第63回日本医学検査学会
    • Place of Presentation
      新潟市 ANAクラウンプラザホテル新潟
    • Year and Date
      2014-05-17 – 2014-05-18
    • Related Report
      2014 Annual Research Report
  • [Presentation] 近位尿細管細胞では、TNF-αはp38MAPK/HSP27経路を介してVEGF-C発現を誘導し、テルミサルタはこれを抑制する。2013

    • Author(s)
      木村秀樹
    • Organizer
      日本腎臓学会
    • Place of Presentation
      東京、 東京国際フォーラム
    • Related Report
      2013 Research-status Report
  • [Presentation] ヒト培養メサンギウム細胞において,テルミサルタンはTGF-β誘導性PAI-1産生をPPAR-δ経路を介して抑制する.2013

    • Author(s)
      三上大輔
    • Organizer
      日本腎臓学会
    • Place of Presentation
      東京 、東京国際フォーラム
    • Related Report
      2013 Research-status Report
  • [Presentation] Vascular Endothelial Growth Factor-C Production Stimulated by TNF-αthrough p38/HSP27 Pathway and Its Therapeutic Reduction in Human Proximal Renal Tubular Cells2013

    • Author(s)
      Kimura Hideki
    • Organizer
      Annual Meeting of American Society of Nephrology
    • Place of Presentation
      Atlanta, USA
    • Related Report
      2013 Research-status Report
  • [Presentation] Telmisartan Activates Endogenous Peroxisome Proliferator-Activated Receptor-δ and May Have Anti-Fibrotic Effects in Human Mesangial Cells2013

    • Author(s)
      Mikami Daisuke
    • Organizer
      Annual Meeting of American Society of Nephrology
    • Place of Presentation
      Atlanta, USA
    • Related Report
      2013 Research-status Report
  • [Presentation] Urinary Podocalyxin Refl ects Podocyte Injury in Hypoxia-Exacerbated Diabetic Glomerulosclerosis2013

    • Author(s)
      Tkahashi Naoki
    • Organizer
      Annual Meeting of American Society of Nephrology
    • Place of Presentation
      Atlanta, USA
    • Related Report
      2013 Research-status Report
  • [Presentation] 近位尿細管細胞に於いて、TNF-aはp38MAPK/HSP27経路を介してVEGF-C発現を誘導し、ステロイドはこれを抑制する。

    • Author(s)
      木村秀樹
    • Organizer
      日本腎臓学会
    • Place of Presentation
      横浜市
    • Related Report
      2012 Research-status Report
  • [Presentation] 近位尿細管細胞では、TNF-αはp38MAPK/HSP27経路を介してVEGF-C発現を誘導し、テルミサルタンはこれを抑制する。

    • Author(s)
      木村秀樹
    • Organizer
      日本腎臓学会
    • Place of Presentation
      東京
    • Related Report
      2012 Research-status Report
  • [Presentation] ヒト培養メサンギウム細胞において,テルミサルタンはTGF-β誘導性PAI-1産生をPPAR-δ経路を介して抑制する.

    • Author(s)
      三上大輔
    • Organizer
      日本腎臓学会
    • Place of Presentation
      東京
    • Related Report
      2012 Research-status Report
  • [Presentation] Role of Renal Hypoxia in the Progression of Experimental Diabetic Nephropathy.

    • Author(s)
      Takahashi Naoki
    • Organizer
      Annual meeting of American Society of Nephrology
    • Place of Presentation
      San Diego, CA, USA
    • Related Report
      2012 Research-status Report

URL: 

Published: 2013-05-31   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi